55p0110, a novel synthetic compound developed from a plant derived backbone structure, shows promising anti-hyperglycaemic activity in mice

HIGHLIGHTS

• who: Barbara Brunmair and colleagues from the Division of Endocrinology and Metabolism, Department of Medicine III, Medical University of Vienna, Vienna, Austria, , pharma Drug Discovery and Development AG, Vienna, Austria have published the article: 55P0110, a Novel Synthetic Compound Developed from a Plant Derived Backbone Structure, Shows Promising Anti-Hyperglycaemic Activity in Mice, in the Journal: PLOS ONE | DOI:10.1371/journal.pone [0126847]. May 14, 2015 of January/22,/2015
• what: As a result of the here described endeavour, the authors report the discovery, development and initial pharmacological characterisation of several highly effective antidiabetic . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.